JPWO2025143000A1 - - Google Patents
Info
- Publication number
- JPWO2025143000A1 JPWO2025143000A1 JP2025567181A JP2025567181A JPWO2025143000A1 JP WO2025143000 A1 JPWO2025143000 A1 JP WO2025143000A1 JP 2025567181 A JP2025567181 A JP 2025567181A JP 2025567181 A JP2025567181 A JP 2025567181A JP WO2025143000 A1 JPWO2025143000 A1 JP WO2025143000A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023221596 | 2023-12-27 | ||
| PCT/JP2024/045859 WO2025143000A1 (ja) | 2023-12-27 | 2024-12-25 | Ｃ３ ｒｎａ配列に基づく新規二本鎖ｒｎａ及びその利用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2025143000A1 true JPWO2025143000A1 (https=) | 2025-07-03 |
Family
ID=96219120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025567181A Pending JPWO2025143000A1 (https=) | 2023-12-27 | 2024-12-25 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2025143000A1 (https=) |
| WO (1) | WO2025143000A1 (https=) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004520287A (ja) * | 2000-11-28 | 2004-07-08 | ユニバーシティ オブ バージニア パテント ファウンデーション | 抗Ｃ３ｂ（ｉ）抗体を用いる癌の予防および治療方法 |
| JP2009521234A (ja) * | 2005-12-22 | 2009-06-04 | エクセジェニックス、インク．ディー／ビー／エー オプコ ヘルス、インク． | 補体系を制御する組成および方法 |
| WO2022251484A1 (en) * | 2021-05-26 | 2022-12-01 | Apellis Pharmaceuticals, Inc. | Treatment of complement-mediated disorders |
| JP2023013932A (ja) * | 2021-07-14 | 2023-01-26 | 東亞合成株式会社 | ＳＡＲＳ－ＣｏＶ－２ ＲＮＡ配列に基づく新規ｓｉＲＮＡ及びその利用 |
-
2024
- 2024-12-25 JP JP2025567181A patent/JPWO2025143000A1/ja active Pending
- 2024-12-25 WO PCT/JP2024/045859 patent/WO2025143000A1/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004520287A (ja) * | 2000-11-28 | 2004-07-08 | ユニバーシティ オブ バージニア パテント ファウンデーション | 抗Ｃ３ｂ（ｉ）抗体を用いる癌の予防および治療方法 |
| JP2009521234A (ja) * | 2005-12-22 | 2009-06-04 | エクセジェニックス、インク．ディー／ビー／エー オプコ ヘルス、インク． | 補体系を制御する組成および方法 |
| WO2022251484A1 (en) * | 2021-05-26 | 2022-12-01 | Apellis Pharmaceuticals, Inc. | Treatment of complement-mediated disorders |
| JP2023013932A (ja) * | 2021-07-14 | 2023-01-26 | 東亞合成株式会社 | ＳＡＲＳ－ＣｏＶ－２ ＲＮＡ配列に基づく新規ｓｉＲＮＡ及びその利用 |
Non-Patent Citations (3)
| Title |
|---|
| LISOWIEC-WACHNICKA, J. ET AL.: "Contribution of 3'T and 3'TT overhangs to the thermodynamic stability of model siRNA duplexes", BIOPHYS. CHEM., vol. 246, JPN6025009490, 2019, pages 35 - 39, ISSN: 0005820769 * |
| NUCLEIC ACIDS RESEARCH, vol. 33, no. 6, JPN7026001111, 2005, pages 1834 - 1847, ISSN: 0005820770 * |
| 高橋朋子他: "RNA干渉法の核酸医薬への利用（１）", 日本核酸医薬学会誌, vol. 21, no. 1, JPN6025009489, 2017, pages 14 - 21, ISSN: 0005820768 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025143000A1 (ja) | 2025-07-03 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251121 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260319 |